Prevalence and antimicrobial resistance of Acinetobacter baumannii isolated from endotracheal aspirates in a tertiary-care intensive care unit from South India
Abstract
Background: Multidrug-resistant (MDR) Acinetobacter baumannii is a major cause of ventilator-associated infections in intensive care units (ICUs), where empirical therapy is often initiated without up-to-date antimicrobial resistance (AMR) surveillance data. This study assessed the prevalence, demographic associations, and antimicrobial susceptibility patterns of MDR A. baumannii isolated from endotracheal (ET) aspirates in a tertiary-care hospital in southern India.
Methods: In this single-center retrospective observational study, 3,540 non-duplicate clinical isolates collected between 2019 and 2025 were analyzed. Bacterial identification and antimicrobial susceptibility testing were performed using the Vitek 2 Compact automated system and the Kirby-Bauer disc diffusion method, with results interpreted in accordance with Clinical and Laboratory Standards Institute (CLSI) performance standards. Receiver operating characteristic (ROC) curve analysis was used to evaluate the discriminatory performance of the commonly used antibiotics, with the results expressed as the area under curve (AUC).
Results: MDR A. baumannii accounted for 20.2% of all isolates, with the highest prevalence among neurosurgical ICU patients (22.1%). Isolates were more frequent in males (74%) and in patients aged ≥30 years. Resistance was highest for carbapenems (meropenem, 66.4%; imipenem, 62.6%), ciprofloxacin (71.8%), and trimethoprim-sulfamethoxazole (53.1%). Amikacin showed the greatest relative…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.